Wolverine Asset Management LLC Invitae Corp Put Options Transaction History

Wolverine Asset Management LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 03, 2022	SELL	$2.13 - $9.01 $79,662 - $336,974	-37,400 Reduced 95.41%	1,800 $4,000
Q1 2022 May 04, 2022	SELL	$6.28 - $15.59 $1.32 Million - $3.26 Million	-209,400 Reduced 84.23%	39,200 $312,000
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $4.86 Million - $6.72 Million	200,000 Added 411.52%	248,600 $7.07 Million
Q2 2021 Aug 13, 2021	BUY	$26.09 - $40.4 $313,080 - $484,800	12,000 Added 32.79%	48,600 $1.64 Million
Q1 2021 May 13, 2021	BUY	$33.06 - $56.93 $33,060 - $56,930	1,000 Added 2.81%	36,600 $1.4 Million
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $320,538 - $470,680	8,200 Added 29.93%	35,600 $1.49 Million
Q2 2020 Aug 13, 2020	BUY	$11.71 - $30.29 $299,776 - $775,424	25,600 Added 1422.22%	27,400 $829,000
Q1 2020 May 13, 2020	BUY	$7.64 - $27.5 $9,932 - $35,750	1,300 Added 260.0%	1,800 $24,000
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $9,425 - $13,750	500 New	500 $9,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.